1. Home
  2. FC vs ATYR Comparison

FC vs ATYR Comparison

Compare FC & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FC
  • ATYR
  • Stock Information
  • Founded
  • FC 1983
  • ATYR 2005
  • Country
  • FC United States
  • ATYR United States
  • Employees
  • FC N/A
  • ATYR N/A
  • Industry
  • FC Other Consumer Services
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FC Consumer Discretionary
  • ATYR Health Care
  • Exchange
  • FC Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • FC 279.6M
  • ATYR 306.2M
  • IPO Year
  • FC 1992
  • ATYR 2015
  • Fundamental
  • Price
  • FC $23.38
  • ATYR $4.47
  • Analyst Decision
  • FC Strong Buy
  • ATYR Strong Buy
  • Analyst Count
  • FC 2
  • ATYR 6
  • Target Price
  • FC $42.50
  • ATYR $18.60
  • AVG Volume (30 Days)
  • FC 77.0K
  • ATYR 1.5M
  • Earning Date
  • FC 06-25-2025
  • ATYR 05-07-2025
  • Dividend Yield
  • FC N/A
  • ATYR N/A
  • EPS Growth
  • FC 8.95
  • ATYR N/A
  • EPS
  • FC 1.34
  • ATYR N/A
  • Revenue
  • FC $286,195,000.00
  • ATYR N/A
  • Revenue This Year
  • FC N/A
  • ATYR $1,264.26
  • Revenue Next Year
  • FC $5.25
  • ATYR $1,239.11
  • P/E Ratio
  • FC $17.41
  • ATYR N/A
  • Revenue Growth
  • FC 2.53
  • ATYR N/A
  • 52 Week Low
  • FC $18.94
  • ATYR $1.42
  • 52 Week High
  • FC $44.46
  • ATYR $4.66
  • Technical
  • Relative Strength Index (RSI)
  • FC 54.57
  • ATYR 73.84
  • Support Level
  • FC $22.65
  • ATYR $3.73
  • Resistance Level
  • FC $23.82
  • ATYR $3.94
  • Average True Range (ATR)
  • FC 0.65
  • ATYR 0.29
  • MACD
  • FC 0.19
  • ATYR 0.11
  • Stochastic Oscillator
  • FC 72.43
  • ATYR 97.39

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: